AstraZeneca shareholders vote in favour of Alexion acquisition
LONDON: A requisite majority of AstraZeneca (LON: AZN) shareholders has approved the proposal to acquire the entire common stock of Alexion Pharmaceuticals Inc., a news release said. AstraZeneca (LON: AZN) continues to expect the acquisition will close in Q3 2021, subject to approval by Alexion shareholders, certain regulatory approvals, and other customary closing conditions. The…